华大基因：生华投资持股降至7.9413%

Core Viewpoint - Shenzhen Shenghua Investment Enterprise (Limited Partnership), a shareholder holding more than 5% of BGI Genomics, plans to reduce its stake by selling 1.2507 million shares, representing 0.2990% of the company's total share capital, decreasing its ownership from 8.2403% to 7.9413% [1] Summary by Category - Shareholder Activity - The reduction in shareholding is scheduled to occur between September 4, 2025, and September 8, 2025 [1] - The share reduction plan has not yet been fully implemented [1]